Post-operative Nausea and Vomiting Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

Jul 2018| TMR727A| Transparency

Report Highlights

Post-operative Nausea and Vomiting (PONV) Market - Overview
This report studies the current as well as future prospects of the global post-operative nausea and vomiting (PONV) market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and provision of drug therapies as well as devices for treatment, and new players planning to enter the market. The report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. The section also provides overall information and data analysis of the global post-operative nausea and vomiting (PONV) market with respect to the leading market segments based on treatment type, distribution channel, and region.

The global post-operative nausea and vomiting market has been segmented based on treatment type, distribution channel, and region. In terms of treatment type, the market has been classified into serotonin antagonists, steroids, dopamine antagonists, nk-1 receptor antagonists, others, and non-pharmacological treatment. Based on distribution channel, the global post-operative nausea and vomiting (PONV) market has been divided into hospital pharmacies, online pharmacies, and retail pharmacies and drug stores.

Each of the market segments has been extensively analyzed based on market-related factors such as increase in incidence rate of PONV in surgical patient population and rise in adoption rate of non-pharmacological methods of treatment. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the PONV market and is likely to influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors are expected to help market players take strategic decisions to strengthen their positions and enhance their shares in the global PONV market.

Geographically, the global PONV market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report provides market size and forecast for the major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the overview section. It also provides market attractiveness analysis and market share analysis of key players, thereby presenting a thorough examination of the overall competitive scenario of the global PONV market.

Major players operating in the global PONV market are Acacia Pharma, F. Hoffmann-La Roche AG, Novartis AG, Ani Pharmaceuticals, Inc., Camurus AB, Sanofi, Helsinn Holding S.A., Eisai Corporation, Merck and Co., and GlaxoSmithKline Corporation.

The global PONV market has been segmented as follows:

Global PONV Market, by Treatment Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Others
Non-pharmacologic Treatment

Global PONV Market, by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores

Global PONV Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
  • Table 2 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 3 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 4 : North America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 5 : North America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 6 : North America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 7 : Europe Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 8 : Europe Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 9 : Europe Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 10 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 11 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 12 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 13 : Latin America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 14 : Latin America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 15 : Latin America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 16 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 17 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 18 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn), by Distribution Channel, 2017
  • Figure 2 : Global Post-operative Nausea and Vomiting (PONV) Market Size, by Treatment Type (US$ Mn), 2017
  • Figure 3 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn), by Region, 2017 and 2026
  • Figure 4 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, 2016–2026
  • Figure 5 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast, 2016–2026
  • Figure 6 : Global Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Treatment Type, 2017 and 2026
  • Figure 7 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Serotonin Antagonists, 2016–2026
  • Figure 8 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Steroids, 2016–2026
  • Figure 9 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Dopamine Antagonists, 2016–2026
  • Figure 10 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by NK1 Receptor Antagonists, 2016–2026
  • Figure 11 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
  • Figure 12 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Non-pharmacologic Treatment, 2016–2026
  • Figure 13 : Global Post-operative Nausea and Vomiting (PONV) Market Attractiveness Analysis, by Treatment Type
  • Figure 14 : Global Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Distribution Channel
  • Figure 15 : Global Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 16 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Hospital Pharmacies, 2016–2026
  • Figure 17 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Online Pharmacies, 2016–2026
  • Figure 18 : Global Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) and Y-o-Y Growth, by Retail Pharmacies and Drug Stores, 2016–2026
  • Figure 19 : Global Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 20 : Global Post-operative Nausea and Vomiting (PONV) Market Attractiveness Analysis, by Region
  • Figure 21 : North America Post-operative Nausea and Vomiting (PONV) Market Value Share, by Country, 2017 and 2026
  • Figure 22 : North America Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Country, 2018–2026
  • Figure 23 : North America Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Treatment
  • Figure 24 : North America Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Treatment, 2018–2026
  • Figure 25 : North America Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Distribution Channel
  • Figure 26 : North America Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 27 : Europe Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 28 : Europe Post-operative Nausea and Vomiting (PONV) Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 29 : Europe Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 30 : Europe Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Treatment
  • Figure 31 : Europe Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Treatment, 2018–2026
  • Figure 32 : Europe Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Distribution Channel
  • Figure 33 : Europe Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 34 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 35 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 36 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 37 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Treatment
  • Figure 38 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Treatment, 2018–2026
  • Figure 39 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Distribution Channel
  • Figure 40 : Asia Pacific Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 41 : Latin America Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 42 : Latin America Post-operative Nausea and Vomiting (PONV) Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 43 : Latin America Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 44 : Latin America Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Treatment
  • Figure 45 : Latin America Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Treatment, 2018–2026
  • Figure 46 : Latin America Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Distribution Channel
  • Figure 47 : Latin America Postoperative Nausea and Vomiting (PONV) Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 48 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 49 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 50 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 51 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Treatment
  • Figure 52 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Treatment, 2018–2026
  • Figure 53 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Value Share Analysis, by Distribution Channel
  • Figure 54 : Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 55 : Acacia Pharma Research & Development Cost, 2015 – 2017 (US$ Mn)
  • Figure 56 : F. Hoffmann-La Roche Ltd Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
  • Figure 57 : F. Hoffmann-La Roche Ltd Breakdown of Net Sales, by Region, 2017
  • Figure 58 : F. Hoffmann-La Roche Ltd Breakdown of Net Sales, by Business Segment, 2017
  • Figure 59 : F. Hoffmann-La Roche Ltd Research & Development Cost, 2015 - 2017 (US$ Mn)
  • Figure 60 : Novartis AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
  • Figure 61 : Novartis AG Breakdown of Net Sales, by Region, 2017
  • Figure 62 : Novartis AG Breakdown of Net Sales, by Business Segment, 2017
  • Figure 63 : Novartis AG Breakdown of Net Sales, by Innovative Medicines Business Units, 2017
  • Figure 64 : ANI Pharmaceuticals Inc. Research & Development Cost, 2015 - 2017 (US$ Mn)
  • Figure 65 : ANI Pharmaceuticals Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
  • Figure 66 : Camurus AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 67 : Camurus AB Breakdown of Net Sales, by Region, 2017
  • Figure 68 : Camurus AB Breakdown of Net Sales, by Business Segment, 2017
  • Figure 69 : Camurus AB Research & Development Cost (US$ Mn), 2016–2017
  • Figure 70 : Sanofi Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
  • Figure 71 : Sanofi Breakdown of Net Sales, by Region, 2017
  • Figure 72 : Sanofi Breakdown of Net Sales, by Business Segment, 2017
  • Figure 73 : Sanofi Breakdown of Net Sales, by Pharmaceuticals, 2017
  • Figure 74 : Eisai Inc. Breakdown of Net Sales, by Region, 2017
  • Figure 75 : Eisai Inc. R&D Intensity Company Level (US$ Mn), 2016–2017
  • Figure 76 : Eisai Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
  • Figure 77 : Helsinn Healthcare S.A. Breakdown of Net Sales, by Region, 2016 (%)
  • Figure 78 : Helsinn Healthcare S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 79 : Merck Group, Revenue (US$ Mn), 2015-2017
  • Figure 80 : EMEND Revenue (US$ Mn), 2015-2017
  • Figure 81 : EMEND Revenue, by Region (%), 2017
  • Figure 82 : GSK’s Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 83 : R&D Expenditure (US$ Mn), GSK Group, 2015-2017
  • Figure 84 : Breakdown of GSK’s Vaccines Segment Net Sales, by Region, 2017
  • Figure 85 : Breakdown of GSK’s Net Sales, by Business Segment, 2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report